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Recent advances in multidetector CT, magnetic resonance
imaging, and ultrasound have led to the detection of
incidental pancreatic and splenic lesions that in the past
remained undiscovered. These incidentalomas are unex-
pected, asymptomatic abnormalities discovered serendi-
pitously while searching for other pathology. These
incidental lesions have created a management dilemma for
both clinicians and radiologists, particularly in the oncol-
ogy patient in whom any mass, clinical or subclinical, war-
rants further evaluation.
Strategies for optimizing patient management have
emerged in terms of deciding which of these incidenta-
lomas can be ignored, which can simply be monitored
over time, and which lesions require more aggressive
workup. Subjecting the patient to unnecessary testing
and treatment carries its own set of risks that can result
in an injurious and expensive cascade of imaging and
intervention. The exhaustive evaluation performed in
some patients reflects the unwillingness of many physi-
cians to accept uncertainty even in the case of a very
rare diagnosis. This unwillingness is in part driven by
varying algorithms with regard to diagnostic and treat-
ment strategies, fear of potential malpractice liability,
and/or anxiety of the patient. In this review, guidelines
concerning the approach to some of the more common
incidental cystic pancreatic lesions including IPMN, SPT
(SPEN), serous cystadenoma, mucinous cystic tumor, as
well as primary and secondary cystic splenic lesions will
be presented.
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